CEACAM5 and cancer: In log-rank test, CEA (>5.0 ng/mL) and CA19-9 (>37 U/mL) positivity were significantly associated with poorer cancer-specific survivals (P = 0.016 and 0.010, respectively) and overall survivals (P = 0.044 and 0.004, respectively) (Fig.2).